Verition Fund Management LLC Amneal Pharmaceuticals, Inc. Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 139,738 shares of AMRX stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,738
Previous 46,344
201.52%
Holding current value
$1.17 Million
Previous $385,000
187.27%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
123MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$124 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$103 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$94.5 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$89.8 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$75.3 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.27B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...